Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Coherus Bio (NQ: CHRS )

1.220 -0.040 (-3.17%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Coherus Bio

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
CHRS Stock Earnings: Coherus BioSciences Beats EPS, Beats Revenue for Q2 2024
CHRS stock results show that Coherus BioSciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Week In Review: Fosun Pharma Plans $690 Million Deal To Privatize Henlius, Its Biologics Subsidiary
Shanghai Henlius Biotech agreed to be a wholly owned subsidiary of Fosun in a $690 million deal that values the company at $1.7 billion. Meanwhile, Suzhou Ascentage Pharma filed to list in the US to... 
Via Talk Markets
CHRS Stock Earnings: Coherus BioSciences Misses EPS, Misses Revenue for Q1 2024
CHRS stock results show that Coherus BioSciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Coherus Biosciences Stock Tumbled on Thursday
The company fell well short of expectations for its fourth quarter. 
Via The Motley Fool
Recap: Coherus BioSciences Q4 Earnings
Via Benzinga
Earnings Preview For Coherus BioSciences
Via Benzinga
Earnings Scheduled For March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
Via Benzinga
Why Coherus BioSciences Stock Jumped Today
As promised, Coherus is using the proceeds of a recent divestiture to pay down debt and reduce interest expenses. 
Via The Motley Fool
Why Coherus BioSciences Stock Is Sinking Today
The positive reaction to Coherus' sale of its ophthalmology franchise to Sandoz didn't last long. 
Via The Motley Fool
Why Coherus Biosciences Popped Today
Coherus is divesting its non-core ophthalmology franchise. 
Via The Motley Fool
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the... 
Via Benzinga
Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
Coherus BioSciences agreed to sell its ophthalmology franchise for $170M to Sandoz. This aligns with CHRS' focus on oncology and will help reduce debt and overhead costs. 
Via Benzinga
Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today?
Cartesian Therapeutics stock is falling on Monday as investors react to a delisting notice for RNAC shares due to its low trading price. 
Via InvestorPlace
Why Is B. Riley Financial (RILY) Stock Down 11% Today?
B. Riley Financial stock is falling on Monday as RILY investors react to reports of an SEC probe and the company's stance on the news. 
Via InvestorPlace
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Is Coherus BioSciences (CHRS) Stock Up 17% Today?
Coherus BioSciences stock is rising on Monday as CHRS investors react to a $170 million divestment of its CIMERLI ophthalmology franchise. 
Via InvestorPlace
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. 
Via Benzinga
FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow Jones futures gaining around 15 points on Thursday. Shares of FLJ Group Limited(NASDAQ: FLJ) rose sharply in pre-market trading. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Coherus BioSciences Stock Jumped Today
Coherus finally received FDA approval for its Udenyca OnBody injector system. 
Via The Motley Fool
Exposures Product Safety
Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Coherus BioSciences Stock Is Climbing Today
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares are trading higher Wednesday after the company announced the FDA approval of its pegfilgrastim delivery device, Udenyca Onbody. 
Via Benzinga
Exposures Product Safety
US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY
U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while... 
Via Benzinga
Topics Stocks
Exposures Product Safety US Equities
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback